<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260224068935N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-03-22</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of pain and anxiety during digital and conventional anesthesia in children</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of Pain and Anxiety Associated with Digital and Conventional Local Anesthesia Injection in Maxillary Primary Canine Teeth in Children Aged 5 to 9 Years</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/89311</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, participants are individually assigned to one of two treatment groups (A and B) using simple randomization with sealed envelopes; for this purpose, 42 cards (21 for treatment A and 21 for treatment B) were prepared, placed in sealed envelopes, and put into a box. Subsequently, the department secretary, unaware of the envelopes’ contents, randomly selects one envelope per participant without replacement, and the corresponding treatment is administered by a pediatric resident in the first visit (conventional for A, digital for B), with the second visit (digital for A, conventional for B) occurring 7 to 14 days later by the same resident; this process ensures allocation concealment, Blinding description: In this study, blinding has been implemented to prevent potential bias in participant responses. Participants will be unaware of which type of anesthesia intervention (digital or conventional) they are receiving during each visit. However, it should be noted that the resident responsible for administering the injections and assessing outcomes (pain and anxiety) is aware of the patients’ treatment group allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Pain from Local Anesthetic Injections. Condition 2: Anxiety from Local Anesthetic Injections.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Digital anesthesia is first applied before the injection of local anesthetic using a benzocaine gel for 1-2 minutes on the previously dried mucosa. For digital anesthesia, the Sleeper One 5 device from Dental Hitec, French, and a short gauge 16 needle are used, following the manufacturer’s instructions. The anesthetic solution used is lidocaine with epinephrine 1:80,000. Intervention 2: Intervention group: first applied before the injection of local anesthetic using a benzocaine gel for 1-2 minutes on the previously dried mucosa.For conventional anesthesia, gauge 30 needles of 16mm length are used. The anesthetic solution used in both methods is lidocaine with epinephrine 1:80,000.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all collected deidentified IPD

When:
starting 12 months after publication

To whom:
The data will be available to all requesters, including researchers and administrators.

Conditions:
Data can be used solely for meta-analysis studies.

Where to obtain:
Applicants should email the corresponding author.

How to obtain:
Applicants should solely email the corresponding author, providing the title of their meta-analysis study and, if registered in PROSPERO, the PROSPERO code.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elham Faroukh-gisvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman -  Islamic republic boulevard - the end of Shafa road - the faculty of dentistry of kerman university of medical sciences</address>
        <city>kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 917 213 1306</telephone>
        <email>Faroukh@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Elham Faroukh gisvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman -  Islamic republic boulevard - the end of Shafa road - the faculty of dentistry of kerman university of medical sciences</address>
        <city>kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 917 213 1306</telephone>
        <email>Faroukh@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>children between 5 and 9 years who need to inject anesthesia in the maxillary canine teeth on both sides of the arch .
they can communicate mentally .
parental consent to the project
patients with rating of frank's behavior 3 and 4</inclusion_criteria>
      <agemin>5 years</agemin>
      <agemax>9 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Children who have used painkillers within 48 hours before treatment.
Children with previous dental experience.
Children with a history of significant behavioral management problems are excluded from the study.
Have a systemic disease.
Have contraindications for the use of local anesthetics.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R52</hc_code>
      <hc_code>F41.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pain, unspecified</hc_keyword>
      <hc_keyword>Anxiety disorder, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Digital anesthesia is first applied before the injection of local anesthetic using a benzocaine gel for 1-2 minutes on the previously dried mucosa. For digital anesthesia, the Sleeper One 5 device from Dental Hitec, French, and a short gauge 16 needle are used, following the manufacturer’s instructions. The anesthetic solution used is lidocaine with epinephrine 1:80,000.</i_keyword>
      <i_keyword>Intervention group: first applied before the injection of local anesthetic using a benzocaine gel for 1-2 minutes on the previously dried mucosa.For conventional anesthesia, gauge 30 needles of 16mm length are used. The anesthetic solution used in both methods is lidocaine with epinephrine 1:80,000</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Heart rate. Timepoint: during injection. Method of measurement: pulls oximeter.</prim_outcome>
      <prim_outcome>Pain. Timepoint: during injection. Method of measurement: according to Wong-baker scale.</prim_outcome>
      <prim_outcome>Physical reaction. Timepoint: during injection. Method of measurement: FLACC pain scale: Face (F): This refers to facial expressions. It includes observing muscle tension, frowning, or whether the eyes or mouth are open or closed. Legs (L): This category assesses the position and movement of the legs. It looks for whether the legs are relaxed, stiff, or if there are any involuntary movements like kicking or thrashing. Activity (A): This evaluates the child's overall activity level. It notes if they are calm, restless, or if their body is rigid. Cry (C): This focuses on the sound the person is making. It ranges from no crying to moaning or loud crying. Consolability (C): This measures how easily the person can be comforted. It assesses whether they can be soothed with touch or reassurance.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-11-02</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Kerman -  Islamic republic boulevard - the end of Shafa road - the faculty of dentistry of kerman university of medical sciences Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
